Latest News & Features
Europe
The company that provides access to CRISPR/Cas9 IP owned by researcher Emmanuelle Charpentier, ERS Genomics, has signed a patent licensing deal with DefiniGEN, a spin-out from the University of Cambridge, UK. 1 November 2018
Big Pharma
Japan-based Takeda Pharmaceuticals is reportedly planning to sell its European over-the-counter business to lessen its debt from acquiring biotech company Shire. 31 October 2018
article
The Medicines and Healthcare Products Regulatory Agency has seized more than £2 million ($2.6 million) worth of counterfeit medication in the UK, according to the a statement made by the UK government. 31 October 2018
Americas
Swiss pharmaceutical company Novartis has partnered with Pfizer, its American rival, in efforts to advance the treatment of non-alcoholic steatohepatitis. 30 October 2018
Americas
Allergan and the Saint Regis Mohawk Tribe have urged the US Court of Appeals for the Federal Circuit to stay its ruling against them pending an appeal to the US Supreme Court. 29 October 2018
Americas
Johnson & Johnson has revealed its intention to appeal against a district court’s invalidation of a patent covering its prostate cancer drug Zytiga (abiraterone acetate). 29 October 2018
Americas
The US Food and Drug Administration’s generic drug approval rate has increased at a “rapid rate” since January 2017, despite the number of branded drug patent expirations declining during this period. 26 October 2018
Americas
More than 500 tonnes of illicit pharmaceuticals have been seized worldwide as part of a global operation led by Interpol, as announced on Tuesday. 26 October 2018
Americas
With several major drugs set to face generic or biosimilar competition as patent protection expires, LSIPR analyses how well prepared their manufacturers are and how badly their sales may be affected. 26 October 2018
Americas
Siew Yen Chong has joined Nelson Mullins Riley & Scarborough’s New York office as of counsel. 26 October 2018